Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report
Autor: | Masafumi Tanaka, Mitsuko Fukunaga, Takafumi Suzuki, Kazutaka Yamada, Yasumitsu Saiki, Kazutsugu Iwamoto, Ryoichi Nozaki |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
Male Abdominal pain medicine.medical_specialty Perforation (oil well) lcsh:Surgery Rectum Case Report Malignancy 03 medical and health sciences 0302 clinical medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Cyclophosphamide Colectomy Ileostomy Rectal Neoplasms business.industry Rectal Ulcer Diffuse large B-cell lymphoma lcsh:RD1-811 General Medicine Prognosis medicine.disease Ulcerative colitis Surgery medicine.anatomical_structure Doxorubicin Vincristine Rectal Perforation 030220 oncology & carcinogenesis Prednisone Colitis Ulcerative Lymphoma Large B-Cell Diffuse Intestinal perforation Radiology medicine.symptom Rituximab business 030217 neurology & neurosurgery |
Zdroj: | BMC Surgery, Vol 21, Iss 1, Pp 1-5 (2021) BMC Surgery |
ISSN: | 1471-2482 |
Popis: | Background Gastrointestinal lymphomas like diffuse large B-cell lymphoma (DLBCL) are rare complications of ulcerative colitis (UC), and only a few studies have reported intestinal ulcers caused by DLBCL, which got perforated during the treatment of UC. Case presentation A 43-year-old man with severe lower abdominal pain and an 8-year history of UC was admitted in our hospital. He was diagnosed UC since 8 years and received a maintenance oral dose of 5-aminosalicylic acid, and no other immunosuppressive drugs. A deep rectal ulcer was endoscopically diagnosed 10 months before admission, no malignancy or cytomegalovirus infection was detected on biopsy. After 7 months a further endoscopy with biopsies confirmed the finding and the absence of malignancy. Three months later the patient developed sudden abdominal pain and was admitted in our hospital. Rectal perforation was suspected on X-ray and computed tomography imaging, and an emergency surgery was performed. Surgical exploration revealed a perforation on the anterior wall of the rectum. A subtotal colectomy with temporary ileostomy was performed. Pathology examinations showed lymphocyte infiltration of all of the layers of the perforated site and an immunohistochemical evaluation revealed DLBCL. Clinical staging was stage IV, and the patient received a 6-months regimen of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. Positron emission tomography restaging revealed disappearance of distant uptake and a slight uptake in the residual rectum, and completion proctectomy with ileal pouch-anal anastomosis was performed. No residual tumor in the specimen was found, and the patient was disease-free at 2 years follow-up. Conclusions DLBCL may increase the frequency of perforation and is a poor prognostic risk factor for patients with UC. This case study emphasizes the importance of careful medical surveillance and repeated endoscopic biopsies during the treatment of UC. |
Databáze: | OpenAIRE |
Externí odkaz: |